Skip to main content

Cigna launches effort to cap employer insurance plan spending on weight loss drugs

Cigna's Evernorth struck agreements with Novo Nordisk and Eli Lilly to limit spending increases for those GLP-1s to a maximum of 15% annually.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.